期刊文献+

依诺肝素钠宽分布相对分子质量对照品研制 被引量:4

Preparation of A Relative Molecular Mass Reference Substance with Broad Distribution for Enoxaparin Sodium
下载PDF
导出
摘要 目的研制一种依诺肝素钠宽分布相对分子质量(Mr)对照品。方法以肝素钠为起始原料,经过成盐、酯化、β-消除降解等步骤制备依诺肝素钠宽分布Mr对照品;以欧洲药典低分子肝素(LMWH)Mr对照品为对照,利用高效分子排阻色谱法(HPSEC)测定自制依诺肝素钠宽分布Mr对照品的Mr及其分布,并与EP对照品比较。分别用自制对照品与EP对照品检测依诺肝素钠原料药的Mr及其分布,并比较检测结果。结果自制对照品与EP对照品的UV图谱与RI图谱相近,Mr及其分布接近,两种对照品测得依诺肝素钠Mr及其分布接近。结论以β-消除降解法制备的依诺肝素钠宽分布Mr对照品可准确测定依诺肝素钠的Mr及其分布,为不同LMWH按各自生产工艺制备其Mr对照品提供参考。 Objective To establish a relative molecular mass (Mr) reference substance (RS) with broad distribution for enoxaparin sodium. Methods A Mr RS with broad distribution for enoxaparin sodium was produced through a series of steps including salification, esterification and β-elimination degradation, using heparin sodium as starting material. Using EP chemical reference substance (CRS) for LMWH as reference substance, the Mr and its distribution of the self-prepared RS with broad distribution was tested by high performance size exclusion chromatography (HPSEC), and compared with Mr and its distribution of EP Mr CRS. The Mr and Mr distribution of several lots of enoxaparin sodium were tested using self-made RS and EP CRS, and the results were compared. Results The UV and RI chromatograms and the Mr and Mr distribution of the self-made RS and EP CRS were similar. The Mr results of enoxaparin sodium were also of no significant difference. Conclusion The enoxaparin sodium Mr RS prepared through β-elimination degradation can accurately test the Mr and Mr distribution of enoxaparin sodium, which providing a reference for preparation of different LMWH Mr RS.
出处 《食品与药品》 CAS 2015年第3期153-156,共4页 Food and Drug
关键词 依诺肝素钠 相对分子质量 高效分子排阻色谱法 对照品 enoxaparin sodium relative molecular mass high performance size exclusion chromatography reference substance
  • 相关文献

参考文献6

二级参考文献68

  • 1王福清,张天民,崔慧斐,许荔新.低抗凝肝素来源低分子肝素的研制及药代动力学[J].中国药学杂志,1994,29(2):99-101. 被引量:4
  • 2曹跃琼,陶元器,杨春雷.肝素中存在的一个不易被亚硝酸降解的片段[J].中国生化药物杂志,1996,17(1):1-4. 被引量:3
  • 3姬胜利,张天民.肝素与低分子肝素的研究进展[J].中国生化药物杂志,1996,17(5):216-219. 被引量:33
  • 4[1]Xue CH,Yu GL,Takashi H,et al.Antioxidative activities of seve ral marine polysaccharides evaluated in a phosphatidylcholine-liposomal suspens ion and organic solvents[J].Biosci Biotechnol Biochem,1998,62(2)∶206-210 .
  • 5[2]Hyun OY,Nur SG,Toshihiko T,et al.Preparation and structural determi nation of dermatan sulfate-derived ologosaccharides[J].Glycobiology, 2000,10(10)∶1033-1037.
  • 6[4]British Pharmacopoeia CD.Low-Molcular-Weight-Heparins[S].1998(Versio n2.0)[s.l.]:stationary office Ltd,1998.606-608.
  • 7Liu YG,Bo SQ,Zhu YJ,et al.Determination of molecular weight and molecular sizes of polymers by high temperature gel permeation chromatography with a static and dynamic laser light scattering detector.Polymer,2003,44(23):7209.
  • 8CHEN Hui-li(陈惠黎),WANG Ke-yi(王克荑).Glycoconjugates Structrue and Fuction(糖复合物结构与功能).Shanghai(上海):Shanghai Medicin University Press(上海医科大学出版社),1997.43.
  • 9McNeal CJ,Macfarlane RD,Jardine I.A novel mass spectrometric procedure to rapidly determine the partial structure of heparin fragments.Biochem Biophys Res Commun,1986,139(1):18.
  • 10Shriver Z,Raman R,Venkataraman G,et al.Sequencing of 3-O sulphate containing heparin decasaccharides with a partial antithrombin III binding site.Proc Natl Acad Sci,2000,97(19):10359.

共引文献51

同被引文献33

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部